Provided by Tiger Fintech (Singapore) Pte. Ltd.

LAVA Therapeutics N.V.

1.51
-0.0200-1.31%
Post-market: 1.510.00000.00%16:10 EDT
Volume:341.46K
Turnover:520.80K
Market Cap:39.72M
PE:-1.43
High:1.55
Open:1.53
Low:1.50
Close:1.53
52wk High:2.09
52wk Low:0.8502
Shares:26.31M
Float Shares:10.22M
Volume Ratio:2.91
T/O Rate:3.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0538
EPS(LYR):-0.9359
ROE:-90.19%
ROA:-21.30%
PB:1.99
PE(LYR):-1.61

Loading ...

Dec 23, 2022

[Rev.]Annual Report

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Dec 12, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 30, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 20, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 24, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 28, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 08, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Mar 31, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Mar 24, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Mar 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 18, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 18, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Mar 10, 2021

Correspondence

CORRESP [Cover] - Correspondence